HK Doctors Prefer Chinese Covid Vaccine: Survey
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1571820_1_20210122181304.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1571820-20210122.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1571820-20210122.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-01-22 HKT 16:18
A pro-government healthcare workers' group and four unions in the medical sector say a survey they've carried out suggests Hong Kong doctors, nurses and dentists prefer China's Sinovac coronavirus jabs to those developed overseas.
Medical Conscience said on Friday that they polled 930 healthcare workers, including 444 doctors and 318 dentists, regarding the three vaccines the Hong Kong government has procured so far.
Sixty-one percent said their preferred vaccine would be the one made by Sinovac, while 22 percent opted for the one made by Germany's BioNTech and 11 percent the jab from Anglo-Swedish company AstraZeneca.
Five percent of the respondents said they would refuse to take Covid-19 vaccines altogether.
Medical Conscience said the survey was carried out between January 7 and January 14.
Researchers in Brazil only made public the findings of their late-stage trials of the Sinovac jabs on January 13, saying it has an efficacy rate of 50.4 percent - lower than those of the other two.
But Dr David Lam from Medical Conscience said many in the medical sector already knew that Sinovac was their favourite, because it is made in a more conventional way, using inactivated virus particles.
"Maybe doctors and nurses are kind of more conservative people so they choose something they know well. That’s probably the reason why more people chose the inactivated virus technology," Lam said at a press conference.
"I wouldn’t really put too much emphasis on the branding of the vaccines, but rather the technology behind them."
Lam also said he has no problem with the government’s plan to prioritise care home residents and staff over healthcare workers when the inoculation programme is launched.
He said while he believes doctors and nurses should be among the first groups of people to get the jabs, they don't need to be right at the front of the queue because they are well-trained and can protect themselves using their professional knowledge.
ZA Bank Brings Nasdaq Data To Hong Kong, Expanding US Stock Access And Investor Education
ZA Bank and Nasdaq have announced a collaboration aimed at enhancing digital wealth management in Hong Kong and interna... Read more
Hong Kong To Study One‑Stop Infrastructure For Equities, Bonds And Digital Assets
The Hong Kong Monetary Authority’s (HKMA) CMU OmniClear and the Hong Kong Exchange (HKEX) are set to begin a study on... Read more
Hong Kong To Issue First Stablecoin Licenses In March, Expand Crypto Regulation
Hong Kong will issue its first licenses for fiat-referenced stablecoin issuers in March and introduce new legislation l... Read more
MSIG Joins US$6B IFC Credit Insurance Facility To Boost Emerging Market Lending
MSIG USA and Mitsui Sumitomo Insurance (MSI Japan), together referred to as MSIG, have joined a new insurance-ba... Read more
Why The $2 Trillion Stablecoin Prediction Is Too Low
McKinsey estimates the stablecoin market will hit $2 trillion by 2028. But according to Sam Lin, COO of dtcpay, even th... Read more
RedotPay Eyes US IPO With Potential US$1 Billion Raise
RedotPay is reportedly exploring an IPO in the US that could raise more than US$1 billion, according to people famili... Read more